Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
AssigneeRosemont Pharmaceuticals Ltd
InventorsTajamal Mustafa, Mark Kneale Foley, Hayley Louise Lonergan, David Robert Thompson
Life of this patent
Estimating the term…
Abstract
The present application relates generally to pharmaceutical compositions comprising a pharmaceutically effective amount of topiramate particles dispersed in suspension, wherein the composition is suitable for oral delivery. The present application also relates generally to novel cold-chain stable formulations of oral liquid suspension dosage forms containing topiramate and a process for producing said oral liquid suspension dosage forms. Also disclosed are improved analytical methods for assaying complex drug formulations containing sulfamate-substituted monosaccharides.
Claims10
A pharmaceutical composition comprising a pharmaceutically effective amount of topiramate particles dispersed in suspension, wherein the composition is suitable for oral delivery.
Dependencies are inferred from the claim text.